Axil Brands, Inc. (AXIL) stock
AXILNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 19/3059% below fair value
$4.81−0.13 (-2.63%)
Close on Nov 18, 2026Market cap $32.82MP/E 14.1Yield –
Axil Brands operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Axil Brands's operating income for the twelve months ending Aug 31, 2026 was $3.00M, up 75.2% year over year. For fiscal 2026 it was $2.98M, up 156.3% from the year before. The highest annual figure on record is $2.98M in fiscal 2026.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $2.98M | +156.3% |
| FY2025 | May 31, 2025 | $1.16M | -22.7% |
| FY2024 | May 31, 2024 | $1.50M | -24.2% |
| FY2023 | May 31, 2023 | $1.98M | – |
| FY2022 | May 31, 2022 | -$211.40K | – |
| FY2021 | May 31, 2021 | -$321.05K | – |
| FY2020 | May 31, 2020 | -$171.12K | – |
| FY2019 | May 31, 2019 | -$149.64K | – |
| FY2018 | May 31, 2018 | -$338.85K | – |
| FY2017 | May 31, 2017 | -$538.21K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $437.03K | +6.1% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $1.45M | +3041.9% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $214.24K | -63.3% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $903.07K | +34.2% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $411.74K | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $46.09K | -72.8% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $583.11K | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $672.87K | -46.8% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$140.70K | -181.0% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $169.59K | -70.9% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$103.88K | -148.0% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $1.26M | +28.3% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $173.76K | -12.9% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $583.23K | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $216.59K | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $985.00K | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $199.40K | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$94.19K | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$97.50K | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$5.24K | -109.6% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$14.47K | – |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -$186.55K | -45710.0% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$121.03K | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $54.56K | – |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | -$68.04K | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $409 | -91.8% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$41.11K | – |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | -$29.89K | – |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$102.87K | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $4.99K | – |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | -$3.51K | – |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | -$58.06K | – |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$93.05K | – |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -$889 | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | -$111.98K | – |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | -$100.28K | – |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | -$125.70K | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -$205.07K | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | -$109.67K | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | -$110.44K | – |
See a number that looks wrong?